Literature DB >> 9862693

Dependence of both spontaneous and antibody-dependent, granule exocytosis-mediated NK cell cytotoxicity on extracellular signal-regulated kinases.

R Trotta1, K A Puorro, M Paroli, L Azzoni, B Abebe, L C Eisenlohr, B Perussia.   

Abstract

Extracellular signal-regulated kinases (ERK, also known as mitogen-activated protein kinases) are serine-threonine kinases transducing signals elicited upon ligand binding to several tyrosine kinase-associated receptors. We have reported that ERK2 phosphorylation and activation follows engagement of the low affinity receptor for the Fc portion of IgG (CD16) on NK cells, and is necessary for CD16-induced TNF-alpha mRNA expression. Here, we analyzed the involvement of ERK in NK cell-mediated cytotoxicity and IFN-gamma expression induced upon stimulation with targets cells, coated or not with Abs. Our data indicate that, as with immune complexes, ERK2 phosphorylation occurs in human primary NK cells upon interaction with target cells sensitive to granule exocytosis-mediated spontaneous cytotoxicity, and that this regulates both target cell- and immune complex-induced cytotoxicity and IFN-gamma mRNA expression. A specific inhibitor of mitogen-activated protein kinase kinase reduced both spontaneous and Ab-dependent cytotoxicity in a dose-dependent manner involving, at least in part, inhibition of granule exocytosis without affecting effector/target cell interaction and rearrangement of the cytoskeleton proteins actin and tubulin. Involvement of ERK in the regulation of Ca2+-dependent cell-mediated cytotoxicity was confirmed, using a genetic approach, in primary NK cells infected with a recombinant vaccinia virus encoding an ERK inactive mutant. These data indicate that the biochemical pathways elicited in NK cells upon engagement of receptors responsible for either spontaneous or Ab-dependent recognition of target cells, although distinct, utilize ERK as one of their downstream molecules to regulate effector functions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9862693

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  37 in total

1.  Immunosuppressive effects of triclosan, nonylphenol, and DDT on human natural killer cells in vitro.

Authors:  Felicia Udoji; Tamara Martin; Rachel Etherton; Margaret M Whalen
Journal:  J Immunotoxicol       Date:  2010 Jul-Sep       Impact factor: 3.000

2.  Dibutyltin activates MAP kinases in human natural killer cells, in vitro.

Authors:  Sabah O Odman-Ghazi; Abraham Abraha; Erica Taylor Isom; Margaret M Whalen
Journal:  Cell Biol Toxicol       Date:  2010-03-24       Impact factor: 6.691

3.  Dysregulation of signaling pathways in CD45-deficient NK cells leads to differentially regulated cytotoxicity and cytokine production.

Authors:  David G T Hesslein; Rayna Takaki; Michelle L Hermiston; Arthur Weiss; Lewis L Lanier
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-20       Impact factor: 11.205

4.  CD19 targeting of chronic lymphocytic leukemia with a novel Fc-domain-engineered monoclonal antibody.

Authors:  Farrukh T Awan; Rosa Lapalombella; Rossana Trotta; Jonathan P Butchar; Bo Yu; Don M Benson; Julie M Roda; Carolyn Cheney; Xiaokui Mo; Amy Lehman; Jeffrey Jones; Joseph Flynn; David Jarjoura; John R Desjarlais; Susheela Tridandapani; Michael A Caligiuri; Natarajan Muthusamy; John C Byrd
Journal:  Blood       Date:  2009-12-02       Impact factor: 22.113

5.  The transcription Factor AHR prevents the differentiation of a stage 3 innate lymphoid cell subset to natural killer cells.

Authors:  Tiffany Hughes; Edward L Briercheck; Aharon G Freud; Rossana Trotta; Susan McClory; Steven D Scoville; Karen Keller; Youcai Deng; Jordan Cole; Nicholas Harrison; Charlene Mao; Jianying Zhang; Don M Benson; Jianhua Yu; Michael A Caligiuri
Journal:  Cell Rep       Date:  2014-06-19       Impact factor: 9.423

6.  Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells.

Authors:  Rossana Trotta; Li Chen; Stefan Costinean; Srirama Josyula; Bethany L Mundy-Bosse; David Ciarlariello; Charlene Mao; Edward L Briercheck; Kathleen K McConnell; Anjali Mishra; Lianbo Yu; Carlo M Croce; Michael A Caligiuri
Journal:  Blood       Date:  2013-02-19       Impact factor: 22.113

7.  The role of p44/42 activation in tributyltin-induced inhibition of human natural killer cells: effects of MEK inhibitors.

Authors:  Abraham B Abraha; Margaret M Whalen
Journal:  J Appl Toxicol       Date:  2009-03       Impact factor: 3.446

8.  Bispecific and trispecific killer cell engagers directly activate human NK cells through CD16 signaling and induce cytotoxicity and cytokine production.

Authors:  Michelle K Gleason; Michael R Verneris; Deborah A Todhunter; Bin Zhang; Valarie McCullar; Sophia X Zhou; Angela Panoskaltsis-Mortari; Louis M Weiner; Daniel A Vallera; Jeffrey S Miller
Journal:  Mol Cancer Ther       Date:  2012-10-17       Impact factor: 6.261

9.  NK cell-activating receptors require PKC-theta for sustained signaling, transcriptional activation, and IFN-gamma secretion.

Authors:  Ilaria Tassi; Marina Cella; Rachel Presti; Angela Colucci; Susan Gilfillan; Dan R Littman; Marco Colonna
Journal:  Blood       Date:  2008-09-10       Impact factor: 22.113

10.  Ly49H signaling through DAP10 is essential for optimal natural killer cell responses to mouse cytomegalovirus infection.

Authors:  Mark T Orr; Joseph C Sun; David G T Hesslein; Hisashi Arase; Joseph H Phillips; Toshiyuki Takai; Lewis L Lanier
Journal:  J Exp Med       Date:  2009-03-30       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.